Deals

AQUA Dermatology Announces Partnership with Steele Dermatology

AQUA Dermatology (“AQUA” or “the Company”) announces a new partnership with Steele Dermatology, a private dermatology practice with two locations in the Atlanta area. AQUA, a scaled provider of comprehensive dermatology services in the Southeast, is backed by leading private equity firms Gryphon Investors and GTCR. Steele Dermatology will continue to be led by board-certified […]

AQUA Dermatology Announces Partnership with Steele Dermatology Read More »

Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectrum Respiratory Endpoint Solutions for Life Sciences

Strados Labs, the respiratory endpoint intelligence company, announces the acquisition of NuvoAir Clinical Trials from NuvoAir Inc. The transaction, which closed in March 2026, expands Strados’ suite of solutions to include remote and in-clinic spirometry, FeNO measurement, and electronic clinical outcome assessment (eCOA) – complementing its existing technologies for cough monitoring and lung sound monitoring

Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectrum Respiratory Endpoint Solutions for Life Sciences Read More »

Roche Boosts Diagnostics Offerings with $595M Saga Buyout

Roche is handing over $595 million to bolster its Foundation Medicine business with a deal to snap up SAGA Diagnostics. Through the deal, the Swiss major gets it hands on Saga’s Pathlight, a personalized, tumor-informed molecular residual disease (MRD) platform. This platform uses structural variant biology, enabling it to be ultra-sensitive in picking up a

Roche Boosts Diagnostics Offerings with $595M Saga Buyout Read More »

Celularity Announces Closing of Transaction with NexGel

Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, announces the closing of its previously announced transaction with NexGel, Inc. (“NexGel”), pursuant to which NexGel acquired certain commercial and other assets related to Celularity’s biomaterials product portfolio and received an exclusive license to develop and commercialize specified products. The transaction is intended

Celularity Announces Closing of Transaction with NexGel Read More »

CBRE Facilitates Sale of Fort Mill MOB Connected to Piedmont Medical Center – Fort Mill Hospital

CBRE is pleased to announce that it facilitated the sale of the Fort Mill On-Campus MOB, a 56,611-square-foot medical outpatient building (MOB) located at 986 Wellness Way, Fort Mill, South Carolina, to INVESCO Real Estate. The Fort Mill On-Campus MOB is a Class A, state-of-the-art facility delivered in 2022, which is directly connected to the

CBRE Facilitates Sale of Fort Mill MOB Connected to Piedmont Medical Center – Fort Mill Hospital Read More »

EnrollHere Inc. Announces Investment from Aquiline to Advance Technology for Medicare Advantage Distribution

EnrollHere Inc., an AI-powered platform and system of record for insurance distribution, announces an investment from Aquiline that will help EnrollHere advance technology for Medicare Advantage distribution, improve enrollment quality, strengthen compliance, and drive greater lifetime value. Founded in 2024 and headquartered in Pinehurst, N.C., EnrollHere supports agencies, field marketing organizations, and carriers operating in

EnrollHere Inc. Announces Investment from Aquiline to Advance Technology for Medicare Advantage Distribution Read More »

Grovecourt Capital Partners with Guide Architecture to Accelerate Growth in Healthcare Design

Grovecourt Capital, a private equity firm focused on partnering with founder-owned businesses, announces its investment in Guide Architecture, a Dallas-based healthcare-focused architecture and planning firm serving leading health systems across the United States. Founded in 2014, Guide Architecture specializes in the planning and design of healthcare facilities, including hospitals, outpatient centers, behavioral health facilities, and

Grovecourt Capital Partners with Guide Architecture to Accelerate Growth in Healthcare Design Read More »

McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions

McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, announces it has entered into a definitive agreement with funds managed by affiliates of Apollo (“Apollo Funds”), under which Apollo Funds will acquire a minority ownership interest in McKesson’s Medical-Surgical Solutions (“MMS”) business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of

McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions Read More »

Lilly to Acquire Kelonia Therapeutics to Advance In Vivo CAR-T Cell Therapies

Eli Lilly and Company (NYSE: LLY) and Kelonia Therapeutics, Inc. (“Kelonia”), a clinical-stage biotechnology company pioneering in vivo gene delivery, announce a definitive agreement for Lilly to acquire Kelonia. Kelonia has developed a proprietary in vivo gene placement system (iGPS® ) that uses specially engineered lentiviral-based particles designed to efficiently and selectively enter T-cells inside

Lilly to Acquire Kelonia Therapeutics to Advance In Vivo CAR-T Cell Therapies Read More »

UCB to Acquire Neurona Therapeutics

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, announces that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead asset NRTX-1001, adding to UCB’s epilepsy portfolio. Neurona Therapeutics is a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for epilepsies and other disorders of the nervous system.

UCB to Acquire Neurona Therapeutics Read More »

Scroll to Top